About Richard Klemke
Form D filings for Cytonus Therapeutics from 2021 to 2023 list Richard Klemke as executive officer and director.
Richard Klemke first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Richard Klemke in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Richard Klemke works with at each company, as listed on that company's latest Form D.
Cytonus Therapeutics, Inc. · Form D, Nov 6, 2023